Current emerging therapeutic targets and clinical investigational agents for schizophrenia: Challenges and opportunities
Sign Up to like & getrecommendations! Published in 2024 at "Medicinal Research Reviews"
DOI: 10.1002/med.22086
Abstract: Since the first discovery of antipsychotics in the 1950s, targeting dopaminergic drugs has manifested to well manage the positive symptoms of schizophrenia with limited efficacy for the negative and cognitive symptoms. In past decades, extensive… read more here.
Keywords: therapeutic targets; investigational agents; targets clinical; clinical investigational ... See more keywords
Pharmacological Strategies for Cataract Management: From Molecular Targets to Clinical Translation
Sign Up to like & getrecommendations! Published in 2025 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms26125658
Abstract: Cataracts, characterized by the opacification of the eye lens, remain a leading cause of reversible blindness globally. Age and diabetes are key risk factors, and with the increasing aging and diabetic population, the global burden… read more here.
Keywords: management molecular; cataract management; molecular targets; strategies cataract ... See more keywords